Engineered nanovesicles from activated neutrophils show promise in treating infected wounds

A recent study has developed nanovesicles (NVs) from activated neutrophils, showcasing their ability to perform molecular debridement and accelerate healing in infectious wounds. This novel method significantly enhances treatment effectiveness, particularly for stubborn diabetic wounds, by targeting and neutralizing deep tissue pathogens.

Cedars-Sinai Again Ranked in Top Tier of U.S. Hospitals

Cedars-Sinai has been named to the Honor Roll for the ninth consecutive year in U.S. News & World Report’s “Best Hospitals 2024-25” rankings.

UT Southwestern once again ranked best hospital in DFW

UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth for the eighth consecutive year and ranks among the nation’s top hospitals for care in 11 specialties – the most of any hospital in Texas, according to U.S. News & World Report’s annual Best Hospitals list released today.

Are GLP-1 drugs safe for children? Doctors say despite high use among youth, no unique health risks detected

With the skyrocketing popularity of weight-loss drugs like Ozempic, Wegovy, and Mounjaro, health experts are noticing an increasing trend of use among younger Americans.  According to new findings published in the Journal of the American Medical Association, the number of teens and young adults prescribed…

Study Suggests States Could Cut Healthcare Costs by Delivering Patient Tailored Meals

According to new research looking at every U.S. state, programs that deliver medically tailored meals (MTMs) to people with diet-sensitive conditions such as diabetes and heart disease along with limitations in the ability to perform daily activities could lead to substantial savings in healthcare costs.

Compound from Olives Shows Promise for Treating Obesity and Diabetes

Findings from a new mouse study suggest that elenolic acid, a natural compound found in olives, can lower blood sugar levels and promote weight loss. The research could pave the way to the development of safe and inexpensive natural products for managing obesity and type 2 diabetes in people.

From the Pakistan-India Border to Our Borderplex: A Doctor’s Journey Dr. Muhammad Moiz Tahir tackles El Paso’s health challenges with community-driven care

EL PASO, Texas — Some people claim borders are barriers. Others see them as frontiers worthy of exploration. Muhammad Moiz Tahir, M.D., is one of the newest assistant professors in the Foster School of Medicine’s Department of Internal Medicine. Dr.…

NUTRITION 2024 Press Materials Available Now

Press materials are now available for NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition (ASN). Top nutrition scientists and practitioners from around the world will gather to share the latest research findings on food and nutrition during the meeting in Chicago from June 29–July 2.

How Your Sleep Patterns Change Can Tell You About Your Health

Your sleep tracker might give you information about more than just your sleep–specifically, it might give you information about chronic conditions such as diabetes and sleep apnea, and illnesses such as COVID-19. This is one of the findings of a study that analyzed data from 5 million nights of sleep across roughly 33,000 people.

Retrospective Study Based on Electronic Health Records Finds Popular Diabetes and Weight-Loss Drugs Associated with Reduction in Incidence and Recurrence of Alcohol-Use Disorder by at Least Half

A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence.

Telemedicine may increase endocrinology care access for under-resourced patients with diabetes and heart disease

Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Two medication classes reduced cardiovascular and liver events in people with type 2 diabetes

GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Metformin may be as safe as insulin during pregnancy, 11-year data shows

Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. This is the first study to look at longer term effects of metformin use during pregnancy.

Anti-obesity medication tirzepatide remains effective even for those with diabetes and other complications

Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

A nanomaterial one-two punch quickly heals wounds in diabetic animal model

Wounds that are superficial for some can be life-threatening for others. With diabetic wounds, healing can be slow, particularly in the feet, increasing the tissue’s susceptibility to infection. Foot ulcers and other diabetic foot complications have similar mortality rates to some cancers, yet progress toward improved treatments has plateaued.

ENDO 2024 press conferences to highlight male birth control, anti-obesity medications

Researchers will delve into emerging research in diabetes, obesity, reproductive health and other aspects of hormone health during the Endocrine Society’s ENDO 2024 news conferences June 1-4.

After spinal cord injury, neurons wreak havoc on metabolism

Conditions such as diabetes, heart attack and vascular diseases commonly diagnosed in people with spinal cord injuries can be traced to abnormal post-injury neuronal activity that causes abdominal fat tissue compounds to leak and pool in the liver and other organs, a new animal study has found.

Study: Inverse Association Found Between Weight Loss Drugs and Multiple Sclerosis, Offering Possible New Avenue To Explore In The Treatment of MS

First, diabetes drugs like Ozempic and Wegovy showed promise in weight loss and have been marketed and widely used for weight loss. Now these medications are showing promise as a possible treatment for multiple sclerosis. A study, “Exploring the association…

Resistant Starch Could Help Combat Leading Cause of End-stage Kidney Failure

Combining a low dose of blood pressure medication with a higher intake of dietary-resistant starch might help stave off diabetic kidney disease, according to results from a new animal study. Researchers will present their work this week at the American Physiology Summit.

Heavy Alcohol Use May Increase Type 2 Diabetes Risk in Middle-aged Adults

Heavy alcohol use may increase middle-aged adults’ risk of developing Type 2 diabetes, according to research to be presented this week at the American Physiology Summit in Long Beach, California. The Summit is the flagship annual meeting of the American Physiological Society (APS).

Transplant doctor discusses how living kidney donors can help those in need of a transplant.

Eric Martinez, MD, at Baylor Scott & White Health, discusses how living kidney donors can help those in need of a transplant.  What You Need to Know: Risk factors that could lead to kidney transplant include high blood pressure and…

Positive Results from Diabetic Foot Ulcer Clinical Trial Show Dramatic Healing Rate within 12 Weeks or Less Using Novel Omeza® Platform and Offloading

Omeza®, a regenerative skincare company that develops marine-based therapies for the treatment of chronic wounds, today presented positive interim data from a diabetic foot ulcer (DFU) clinical trial showing that Omeza® OCM™ plus offloading of weight on the affected foot achieved a 91 percent area reduction (PAR) rate in DFUs within twelve weeks, and a 63 percent PAR within four weeks.

The US Food and Drug Administration issued a warning about the risks of using smartwatches and smart rings that claim to measure blood glucose levels without piercing the skin.

Sabyasachi Sen, a medicine and biochemistry professor at the George Washington University School of Medicine and Health Sciences is available to speak about the warning and what diabetics should rely on to measure their blood sugar for the most accurate…